Discover
PYXS
Pyxis Oncology, Inc.
2.85
2 x 2.24
2 x 3.63
bid
ask
-
0.16
5.32%
2 @ 04:00 PM
2.90 +0.05 (1.75%)
| Ytd | 147.83% | |
| 1y | 137.50% |
2.83
day range
3.19
0.97
52 week range
5.55
| Open | 3.01 | Prev Close | 3.01 | Low | 2.83 | High | 3.19 | Mkt Cap | 180.56M |
| Vol | 773.19K | Avg Vol | 761.51K | EPS | -1.30 | P/E | N/A | Forward P/E | -1.40 |
| Beta | 1.28 | Short Ratio | 3.13 | Inst. Own | 56.55% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 2.01 | 200-d Avg | 2.32 | 1yr Est | 10.00 |
| Income Statement | |||
| Operating Expenses | 24.36M | ||
| Research and Development Expense | 19.98M | ||
| Selling, General and Administrative Expense | 4.38M | ||
| Operating Income | -24.36M | ||
| Net Income | -23.27M | ||
| Net Income Common Stock | -23.27M | ||
| Net Income Common Stock (USD) | -23.27M | ||
| Consolidated Income | -23.27M | ||
| Earnings per Basic Share | -0.37 | ||
| Earnings per Basic Share (USD) | -0.37 | ||
| Earnings per Diluted Share | -0.37 | ||
| Earning Before Interest & Taxes (EBIT) | -23.27M | ||
| Earning Before Interest & Taxes (USD) | -23.27M | ||
| Weighted Average Shares | 63.47M | ||
| Weighted Average Shares Diluted | 63.47M | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.24M | ||
| Cash and Equivalents (USD) | 7.24M | ||
| Investments | 35.25M | ||
| Investments Current | 35.25M | ||
| Current Assets | 45.57M | ||
| Property, Plant & Equipment Net | 18.73M | ||
| Total Assets | 64.30M | ||
| Debt Current | 1.76M | ||
| Total Debt | 18.26M | ||
| Current Liabilities | 16.53M | ||
| Debt Non-Current | 16.50M | ||
| Total Liabilities | 33.03M | ||
| Accumulated Retained Earnings (Deficit) | -466.45M | ||
| Shareholders Equity | 31.27M | ||
| Shareholders Equity (USD) | 31.27M | ||
| Assets Non-Current | 18.73M | ||
| Total Debt (USD) | 18.26M | ||
| Liabilities Non-Current | 16.50M | ||
| Trade and Non-Trade Payables | 4.99M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 687.00K | ||
| Net Cash Flow from Financing | -25.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -9.66M | ||
| Net Cash Flow from Investing | 16.37M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 16.37M | ||
| Net Cash Flow from Operations | -26.00M | ||
| Share Based Compensation | 1.21M | ||